Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-21-101661
Filing Date
2021-08-06
Accepted
2021-08-06 19:00:37
Documents
1
Period of Report
2021-07-31

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm2124283-1_4seq1.html 4  
1 OWNERSHIP DOCUMENT tm2124283-1_4seq1.xml 4 4452
  Complete submission text file 0001104659-21-101661.txt   6016
Mailing Address 910 CLOPPER ROAD SUITE 201S GAITHERSBURG MD 20878
Business Address 910 CLOPPER ROAD SUITE 201S GAITHERSBURG MD 20878 2406541450
Altimmune, Inc. (Issuer) CIK: 0001326190 (see all company filings)

EIN.: 202726770 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 910 CLOPPER ROAD, SUITE 201S GAITHERSBURG MD 20878
Business Address
Roberts M Scot (Reporting) CIK: 0001705905 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-32587 | Film No.: 211154202